Melas Kyriazi Theo
SEC-identified person · CIK 1216078 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Evelo Biosciences, Inc. EVLO | Director | filed 2018 - 2023 |
| Codiak Biosciences, Inc. CDAK | Director | filed 2020 - 2023 |
| Kaleido Biosciences, Inc. KLDO | Director | filed 2019 - 2021 |
| Valeant Pharmaceuticals International, Inc. vrx | Director | filed 2010 - 2016 |
| Valeant Pharmaceuticals International VRX | Director | filed 2006 - 2010 |
| Helicos Biosciences Corp HLCS | Director | filed 2007 - 2010 |
| Glenrose Instruments Inc. NONR | Director | filed 2007 - 2007 |
| Cyberkinetics Neurotechnology Systems, Inc. CYKN.OB | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.